GSK News

GSK will invest up to £600k to support 'Trust in Science' initiative
Express Pharma, 29/07/2019

GSK to fund doctoral programs at Regional Centre for Biotechnology
The Economic Times, 26/06/2019

Govt ties up with GSK Pharma for raising PhD cadre
The Hindu BusinessLine, 26/06/2019

Technology is the tail wind that healthcare needs
ET HealthWorld, 19/12/2018

India adopts new strategy to accelerate lymphatic filariasis elimination
Business Standard, 13/06/2018

Quality is a continuous journey, not a destination : A. Vaidheesh
ET HealthWorld, 06/06/2018

Annaswamy Vaidheesh interview: 'There's general consensus that next price control will happen in 2021'
Indian Express, 23/2/2018

Forbes India Conversations: From globalisation to glocalisation
Forbes India, 22/2/2018

GSK drops Bell Curve appraisals
The Times of India, 09/12/2017

Think you’re too old to be vaccinated? You’re not!
Express Pharma, 24/11/2017

Vaidheesh elected President of Organisation of Pharmaceuticals Producers of India
Express Pharma, 25/09/2017

Pharma reps should be motivated to focus on knowledge transfer rather than sales: Annaswamy Vaidheesh, GSK
Economic Times, 28/07/2017

ARMMAN wins share of GSK and Save the Children Healthcare Innovation Award
The CSR Journal, 03/06/2017

mMitra wins healthcare innovation award
The Hindu, 03/06/2017

GSK Resetting Old And Building New Product Planks In India
Scrip, 02/05/2017

Era of Electroceuticals coming soon?
Express Pharma, 07/03/2017

GSK's Vallance On Efficiency In R&D And Entering "The Cure" Era
Scrip, 20/02/2017

Watch Patrick Vallance, President - R&D, GSK talk about plans to expand our R&D base in India
Moneycontrol, 10/02/2017

GSK features prominently amongst the top 10 in sustainability index list
Business Standard, 26/01/2017

A Helping Hand
Express Pharma, 20/01/2017

Interview with A. Vaidheesh in Express Pharma
Express Pharma, 03/01/2017

Watch Vaidheesh talk about the growth potential of the pharmaceutical industry in India
CNBC Asia, 05/12/2016

India is one of the most important markets for GlaxoSmithKline: Sir Andrew Witty, CEO, GSK
Your Story, 09/11/2016

Sensible pricing helps GSK in India, says CEO
Times of India, 09/11/2016

Andrew Witty leaves GSK with new challenges, robust pipeline
Economic Times, 09/11/2016

Pricing pressure in US will continue: CEO GlaxoSmithKline Plc
Business Standard, 09/11/2016

Expect drug pricing pressure to continue in next few years: GSK
CNBC / moneycontrol , 09/11/2016

GSK's Witty bullish on emerging markets, seeks `predictability' in India
The Hindu Business Line, 08/11/2016

Drug Prices to Drop Regardless of U.S. Vote Outcome, Witty Says
Bloomberg, 08/11/2016

Glaxo Can't Rule Out More U.S. Pharma Regulation: Witty
Bloomberg, 08/11/2016

Interview: GSK India's Playbook For Vaccines Dominance

Conserving antibiotics: Indian researchers invited to bid for £10 mn health innovation prize
Hindustan Times, 27/07/2016

What the "Andrew Witty phase" has meant for GSK in India
Business Today, 25/07/2016

GlaxoSmithKline rolls out code for ethical marketing
The Times of India, 06/07/2016

Only One Big Drugmaker Is Working on a Nanobot Cure
Bloomberg, 09/06/2016

GSK pitches to participate in the Universal Immunisation Programme
The Hindu Business Line, 26/04/2016

Companies share best practices, learn from each other
The Times of India, Business, 21/04/2016

GSK to Launch Free Healthcare Plan for Employess on World Health Day
The Economic Times, 06/04/2016

Vaccination isn't Just a Kids' Thing
The Economic Times, 26/03/2016

I don't want to be big for sake of it: Glaxosmithkline CFO Simon Dingemans
The Economic Times, 14/03/2016

GSK's Ribeiro On Flexible Pricing And Seretide Growth In EMs

India Can Leap Over the World
The Economic Times 30/01/2016

Govt. & Corporates can Together Shape India Story: CEOs
The Economic Times 30/01/2016

GSK Pharma to invest Rs.1,000 cr in tablets, capsules unit near Bengaluru

INDIA INC'S elder statesman Rahul Bajaj and Vedanta boss Anil Agarwal were just two of the many from the power set having a good time. And ministers with powerful portfolios, Venkaiah Naidu and Ravi Shankar Prasad for example, found much that was an informative as it was entertain­ing.

Basics can Keep India Healthy: Witty
The Economic Times 28/01/2016

Immunocore, GSK select first ImmTAC clinical candidate in discovery collaboration
Pharmabiz, 08/01/2016

New drugs in 2015 31/12/2015

Can this vaccine check cervical cancer?
The Indian Express 30/12/2015

Corporate Social Responsibility: Present Trend and Benefits 30/12/2015

HPV vaccine in universal immunisation could bring up old fears 28/12/2015

GSK divests ofatumumab drug for auto-immune indications to Novartis
Pharmabiz 23/12/2015

GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 mln 19/12/2015

GlaxoSmithKline gets lift from successful arthritis drug trials
The Economic Times 17/12/2015

Propeller Health inks pact with GSK to develop digital sensor for Ellipta inhaler
Pharmabiz 03/12/2015

GSK Pharma steps up vaccine biz in India
Business Standard 18/11/2015

In September GSK acquired Novartis's vaccine business. Lines up two vaccine launches for 2016
Aneesh Phadnis | Mumbai, 17/11/2015

GlaxoSmithKline: British pharmaceutical giant marks 300th anniversary 10/11/2015

GSK’s Advair Diskus meets primary endpoint in LABA safety study of patients with asthma
Pharmabiz 30/10/2015

GlaxoSmithKline net earnings jump by 68% in Q3 to £647 mn
Pharmabiz 30/10/2015

GSK seeks EMA approval for chlorhexidine gel for prevention of umbilical cord infections in newborn babies
Pharmabiz 16/10/2015

GSK India Lines Up Growth Plans to Gain Lost Ground
The Economic Times 01/10/2015

Malaria vaccine clears first hurdle
The Times Of India, 25/07/2015